Skip to content

Deep Neuromuscular Block During General Anaesthesia in Robotic Surgery

Deep Neuromuscular Block During General Anaesthesia in Laparoscopic (and Robotic Laparoscopic) Surgery and Its Potential Benefits for Certain Physiological Parameters in Perioperative Period

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03420937
Enrollment
138
Registered
2018-02-05
Start date
2016-06-30
Completion date
2017-08-31
Last updated
2018-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complication of Ventilation Therapy, Observation of Neuromuscular Block, Postoperative Recovery

Keywords

deep neuromuscular block, laparoscopic surgery, robotic surgery, lung protective ventilation, respiratory functions, post-operative recovery

Brief summary

The aim of this project is to show, whether the use of the deep neuromuscular block in certain laparoscopic robot-assisted surgery can positively influence main physiological functions compared to the use of standard neuromuscular block. Secondary outcome is to find out whether the targeted specific reversal of neuromuscular block by sugammadex improves and fastens the post-operative recovery of the patients.

Detailed description

Adequate muscle relaxation during general anaesthesia is crucial for easy, uncomplicated and safe laparoscopic and robot-assisted surgery. Perfect abdominal wall relaxation facilitates surgical working conditions, which makes surgery safer, faster and easier to perform. Besides this indirect advantage, there could be obvious benefit for patients. This is a result of decreased negative pathophysiological consequences of an increased intraabdominal pressure (capnoperitoneum) on important organ systems (cardiovascular, breathing system, kidneys etc.) Complete muscle relaxation during general anaesthesia can be achieved by using higher doses of rocuronium (non-depolarizing aminosteroid muscle relaxant) and special anaesthetic technique called deep neuromuscular block (DNMB). The primary focus of the project is to test the potential advantages of DNMB compared to standard relaxation technique. Safe and efficient use of NMBA is an important precondition in restoring a patient´s full muscle strength at the end of anaesthesia, to prevent effects of residual block. Modern practice of anaesthesia offers an option for complete and immediate rocuronium induced block reversal by using its specific antagonist - sugammadex. Combination of DNMB approach and sugammadex reversal also provide potential benefits for perioperative course and patient recovery after surgery. Secondary objective of the project is to verify this facts.

Interventions

DRUGSugammadex

Deep neuromuscular block provided by rocuronium to PTC 1-2. Reversal of the block with sugammadex.

DRUGNeostigmine, Atropin Biotika

Standard neuromuscular block provided by rocuronium to TOF-count 1-2. Reversal of the block with neostigmine.

Sponsors

Palacky University
CollaboratorOTHER
University Hospital Olomouc
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age over 18 years * Informed Consent * Elective robotic radical prostatectomy * American Society of Anesthesiologists (ASA) status 1-3

Exclusion criteria

* Inability to obtain Informed ConsentAge under 18 years * American Society of Anesthesiologists (ASA) status over 3 * Indication for rapid sequence induction, signs of difficult airway severe neuromuscular, liver or renal disease * Known allergy to drugs used in the study * Malignant hyperthermia (medical history)

Design outcomes

Primary

MeasureTime frameDescription
Surgical conditions SRSPerioperative periodDescribes the quality of surgical conditions as reported by surgeon
Intraabdominal pressure IAP (mmHg)During surgeryPressure in the abdominal cavity during capnoperitoneum

Secondary

MeasureTime frameDescription
Operating theatre time (min)during anesthesiaTime from induction to anesthesia to the release from operating theatre
Post-operative recoverypost-operative period (1 week)Physiological functions, level of discomfort, subjective evaluation by the patient

Countries

Czechia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026